VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,439,813 | -77.4% | 153,662 | -40.9% | 0.00% | -100.0% |
| Q2 2023 | $6,372,796 | +3.1% | 259,796 | -2.2% | 0.00% | – |
| Q1 2023 | $6,179,488 | +246.6% | 265,556 | +276.9% | 0.00% | – |
| Q4 2022 | $1,783,090 | +95.1% | 70,450 | +48.5% | 0.00% | – |
| Q3 2022 | $914,000 | +5.1% | 47,440 | +38.7% | 0.00% | – |
| Q2 2022 | $870,000 | +5.3% | 34,195 | +6.4% | 0.00% | – |
| Q1 2022 | $826,000 | -93.0% | 32,132 | -88.7% | 0.00% | -100.0% |
| Q4 2021 | $11,876,000 | – | 283,646 | +28364500.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |